Children in Research Policy SOP

This standard operating procedure (SOP) includes the following sections: PurposeProcedureContacts, and Links.

Some links will work for NIAID staff only.

Purpose

To increase participation of children in human subjects research so investigators can gather data to support treatments that may affect children.

Procedure

You must include children in all human subjects research conducted or supported by NIH unless you have scientific or ethical reasons for excluding them.

NIH developed its inclusion of children policy because medical treatments used in children are frequently based on tests performed only on adults, and children have less access to scientifically evaluated treatments because of barriers that exclude them from research studies.

NIH policy defines a child as a person under the age of 18, which aligns NIH’s definition with the typical age of consent. It applies to all human subjects research, including research that is exempt from other human subjects requirements according to Sections 101 (b) and 401 (b) of 45 CFR 46—HHS policy for Protection of Human Subjects.

NIH-funded research using newborn dried blood spots is considered human subjects research as defined in section 46.102(f)(2) and must follow the HHS policy for Protection of Human Subjects 45 CFR 46.

Studies may use a specific age range of children. Investigators must provide a rationale for including or excluding an age group. For more details, see NIH Inclusion of Children as Participants in Research Involving Human Subjects and Office for Human Research Protections Special Protections for Children as Research Subjects.

Investigators

  • Describe plans for including children in grant applications and contract proposals involving human subjects.
    • Follow human subjects instructions as well as any special instructions in the funding opportunity announcement or solicitation.
  • If you are including or excluding a specific age group of children, provide a justification.
  • If excluding children altogether, provide the scientific or ethical reasons for doing so.
  • If you propose using newborn dried blood spots in research, include a complete human subjects section according to NIH instructions. Note: You must obtain parental permission to use newborn dried blood spots in NIH-funded research. No waiver of parental permission is permitted.

To learn more, see Human Subjects—WarningResearch Using Human Subjects, and the Bars to Grant Awards SOP.

After award, you must request prior approval to change human subjects involvement. If applicable, include documentation of new or revised inclusion plans for children in your written request.

Center for Scientific Review and Scientific Review Program Staff

  • Before initial peer review, determine if applications meet requirements for including children in the research.
  • Ask reviewers to assess the appropriateness of the justification provided for including or excluding children and, if applicable, for including or excluding a specific age group.
  • Include appropriate expertise on the review panel for the review of applications involving children.
  • Following the review of grant applications, assess the review panel's recommendations, document the final opinion in the summary statement, and record the human subjects and child inclusion codes in IMPAC II.

Program Officers

  • Resolve inclusion of children compliance issues for applications coded unacceptable before funding.

Grants Management Staff and Program Officers

Contacts

See the GMP Assignments by Geographic Region and Program Code for the appropriate specialist.

Contact for NIAID Staff

If you have knowledge to share or want more information on this topic, email deaweb@niaid.nih.gov with the title of this page or its URL and your question or comment. Thanks for helping us clarify and expand our knowledge base.

Links

Content last reviewed on April 10, 2018